Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated According to Uridine Diphosphate Glucuronosyltransferase 1A1 Genotyping in Patients With Metastatic Colorectal Cancer

We analyzed the results of previously treated patients with metastatic colorectal cancer (mCRC) who received regorafenib plus FOLFIRI with the irinotecan dose escalation on the basis of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping. Thirteen patients with previously treated mCR...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncol Res
Hlavní autoři: Ma, Cheng-Jen, Huang, Ching-Wen, Yeh, Yung-Sung, Tsai, Hsiang-Lin, Hu, Huang-Ming, Wu, I-Chen, Cheng, Tian-Lu, Wang, Jaw-Yuan
Médium: Artigo
Jazyk:Inglês
Vydáno: Cognizant Communication Corporation 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840952/
https://ncbi.nlm.nih.gov/pubmed/27938508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/97818823455816X14786040691928
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky